Your browser doesn't support javascript.
loading
When and How To Perform Active Surveillance for Low-risk Non-muscle-invasive Bladder Cancer.
Contieri, Roberto; Lazzeri, Massimo; Hurle, Rodolfo.
Affiliation
  • Contieri R; Department of Biomedical Sciences, Humanitas University, Pieve Emanuele, Italy; Department of Urology, IRCCS Humanitas Research Hospital, Rozzano, Italy. Electronic address: contieri.ro@gmail.com.
  • Lazzeri M; Department of Urology, IRCCS Humanitas Research Hospital, Rozzano, Italy.
  • Hurle R; Department of Urology, IRCCS Humanitas Research Hospital, Rozzano, Italy.
Eur Urol Focus ; 9(4): 564-566, 2023 07.
Article in En | MEDLINE | ID: mdl-37059619
Active surveillance (AS) has been proposed as a possible management option for patients with recurrent low-grade non-muscle-invasive bladder cancer. Recent studies suggest that AS is a safe and effective management strategy. Nevertheless, a consensus statement is needed to standardize inclusion criteria and follow-up schedules.
Subject(s)
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Urinary Bladder Neoplasms / Non-Muscle Invasive Bladder Neoplasms Type of study: Etiology_studies / Risk_factors_studies / Screening_studies Limits: Humans Language: En Journal: Eur Urol Focus Year: 2023 Document type: Article Country of publication:
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Urinary Bladder Neoplasms / Non-Muscle Invasive Bladder Neoplasms Type of study: Etiology_studies / Risk_factors_studies / Screening_studies Limits: Humans Language: En Journal: Eur Urol Focus Year: 2023 Document type: Article Country of publication: